Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging
Condition(s):Left Ventricular HypertrophyLast Updated:July 25, 2019Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Left Ventricular HypertrophyLast Updated:July 25, 2019Not yet recruiting
Condition(s):Major HepatectomyLast Updated:April 30, 2020Completed
Condition(s):Hypertrophic CardiomyopathyLast Updated:March 11, 2021Unknown status
Condition(s):Type 2 Diabetes; Left Ventricular HypertrophyLast Updated:July 9, 2019Completed
Condition(s):Synovial Hypertrophy Hand (Diagnosis)Last Updated:December 1, 2020Unknown status
Condition(s):Diabetes Mellitus Nos New Onset; Hypertrophy, Left Ventricular; Vascular StiffnessLast Updated:November 7, 2013Completed
Condition(s):Left Ventricular Hypertrophy; Diastolic Dysfunction; Heart Failure; Heart RateLast Updated:August 6, 2012Terminated
Condition(s):Benign Masseteric HypertrophyLast Updated:July 27, 2023Recruiting
Condition(s):HypertrophyLast Updated:August 3, 2021Completed
Condition(s):Left Ventricular HypertrophyLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.